Pavion Blue Capital’s Gilead Sciences GILD Stock Holding History

Pavion Blue Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$327K	Hold	2,345	–	–	0.14%	77
2025 Q4	$288K	Hold	2,345	–	–	0.12%	83
2025 Q3	$260K	Hold	2,345	–	–	0.11%	89
2025 Q2	$260K	Hold	2,345	–	–	0.12%	86
2025 Q1	$263K	Hold	2,345	–	–	0.13%	85
2024 Q4	$217K	Buy	+2,345	New	+$211K	0.1%	96
2023 Q2	–	Sell	-2,440	Closed	-$202K	–	100
2023 Q1	$202K	Hold	2,440	–	–	0.12%	96
2022 Q4	$209K	Buy	+2,440	New	+$193K	0.13%	90

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pavion Blue Capital's GILD Position: Q1 2026 in Review

Pavion Blue Capital held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,345 shares worth $327K. The position accounts for 0.14% of the portfolio, ranked #77.

Pavion Blue Capital first reported a position in GILD in Q4 2022 and has held it in 8 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Pavion Blue Capital held 2,345 shares of Gilead Sciences worth $327K as of Q1 2026.
Pavion Blue Capital left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.14% of Pavion Blue Capital's portfolio in Q1 2026, its #77 holding.
Pavion Blue Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 8 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.